Akioka K, Okamoto M, Ushigome H, Nobori S, Suzuki T, Sakamoto S, Yoshimura N
Kyoto Prefectural University of Medicine, Department of Organ Transplant and Endocrine Surgery, Kyoto, Japan.
Transplant Proc. 2009 Jan-Feb;41(1):446-9. doi: 10.1016/j.transproceed.2008.08.141.
Marginally appropriate donors may be considered to extend the donor criteria for renal transplantation because of the donor shortage. We have reported a successful outcome after kidney transplantation from a living-related donor diagnosed with membranous nephropathy.
A 38-year-old man began continuous ambulatory peritoneal dialysis (CAPD) at the age of 37. His 63-year-old father showed mild proteinuria, diagnosed as membranous nephropathy by needle biopsy. However, the father had normal renal function on preoperative examination, except for mild proteinuria. After adequate informed consent, we transplanted a kidney from the father who was diagnosed with membranous nephropathy into his son using a cyclosporine (CsA)-based immunosuppressive regimen. The postoperative course was good in both the recipient and the donor without rejection or infection. At 57 months after transplantation, the serum creatinine level was 1.7 mg/dL in the recipient and 1.2 mg/dL in the donor. An allograft needle biopsy at 39 months after transplantation showed mild spike formation with partial thickening of the glomerular basement membrane (GBM). Electron microscopy showed decreased electron-dense deposits and electron-lucent washout lesions with thickening of the GBM. This was diagnosed as stage IV membranous nephropathy, resulting from clearance of immune complexes and histological repair of the GBM.
For the present donor, graft donation did not affect his residual renal function. Preexisting membranous nephropathy itself may show remission after transplantation into the recipient to achieve successful results, however, long-term careful observation of both the donor and recipient is required.
由于供体短缺,可考虑将边缘合适的供体纳入肾移植供体标准范围。我们曾报道过一例亲属活体供肾诊断为膜性肾病,肾移植后获得成功的病例。
一名38岁男性在37岁时开始持续非卧床腹膜透析(CAPD)。他63岁的父亲有轻度蛋白尿,经肾穿刺活检诊断为膜性肾病。然而,父亲术前检查除轻度蛋白尿外,肾功能正常。在获得充分知情同意后,我们采用以环孢素(CsA)为基础的免疫抑制方案,将诊断为膜性肾病的父亲的一个肾移植给了他的儿子。受体和供体术后过程均良好,未发生排斥反应或感染。移植后57个月时,受体血清肌酐水平为1.7mg/dL,供体为1.2mg/dL。移植后39个月时的移植肾穿刺活检显示有轻度钉突形成,伴肾小球基底膜(GBM)部分增厚。电镜检查显示电子致密沉积物减少,电子透亮洗脱性病变,GBM增厚。这被诊断为IV期膜性肾病,是免疫复合物清除和GBM组织学修复的结果。
对于本例供体,捐肾未影响其残余肾功能。供体原有的膜性肾病本身在移植给受体后可能会缓解,从而获得成功结果,然而,需要对供体和受体进行长期密切观察。